Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Nasal type extranodal NK/T cell lymphoma diagnosed in a patient with rheumatoid arthritis under methotrexate.

Terroso G, Aleixo J, Bernardes M, Mariz E, Fonseca E, Costa L.

Acta Reumatol Port. 2014 Jan-Mar;39(1):77-81.

2.

Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate.

Kondo S, Tanimoto K, Yamada K, Yoshimoto G, Suematsu E, Fujisaki T, Oshiro Y, Tamura K, Takeshita M, Okamura S.

Virchows Arch. 2013 Apr;462(4):399-407. doi: 10.1007/s00428-013-1389-1. Epub 2013 Mar 14.

PMID:
23494713
3.

[Extranodal NK/T-cell lymphoma, nasal type, developed in a patient with rheumatoid arthritis].

Arai H, Maki K, Tadokoro J, Nakamura Y, Sasaki K, Mitani K.

Rinsho Ketsueki. 2011 Jul;52(7):551-5. Japanese.

PMID:
21821989
4.

Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.

Miyazaki T, Fujimaki K, Shirasugi Y, Yoshiba F, Ohsaka M, Miyazaki K, Yamazaki E, Sakai R, Tamaru J, Kishi K, Kanamori H, Higashihara M, Hotta T, Ishigatsubo Y.

Am J Hematol. 2007 Dec;82(12):1106-9.

5.

Epstein-Barr virus and methotrexate-related CNS lymphoma in a patient with rheumatoid arthritis.

Migita K, Miyashita T, Mijin T, Sakito S, Kurohama H, Ito M, Toda K, Tsustumi K, Baba H, Izumi Y, Kawakami A, Niino D, Ohshima K.

Mod Rheumatol. 2013 Jul;23(4):832-6. doi: 10.1007/s10165-012-0717-7. Epub 2012 Jul 24.

PMID:
22825547
6.

Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report.

Kuroda T, Sato H, Nakatsue T, Wada Y, Murakami S, Nakano M, Narita I.

BMC Res Notes. 2014 Apr 11;7:229. doi: 10.1186/1756-0500-7-229.

7.

Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.

Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, Schultz M, Murren J.

J Clin Oncol. 1996 Jun;14(6):1943-9. Review.

PMID:
8656264
8.

Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.

Yamada K, Oshiro Y, Okamura S, Fujisaki T, Kondo S, Nakayama Y, Suematsu E, Tamura K, Takeshita M.

Histopathology. 2015 Jul;67(1):70-80. doi: 10.1111/his.12627. Epub 2015 Feb 5.

PMID:
25429725
9.
10.

Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment.

Georgescu L, Quinn GC, Schwartzman S, Paget SA.

Semin Arthritis Rheum. 1997 Jun;26(6):794-804. Review.

PMID:
9213378
11.

Epstein-Barr virus-positive oral ulceration simulating Hodgkin lymphoma in a patient treated with methotrexate: case report and review of the literature.

Naidu A, Kessler HP, Pavelka MA.

J Oral Maxillofac Surg. 2014 Apr;72(4):724-9. doi: 10.1016/j.joms.2013.09.013. Epub 2013 Nov 15. Review.

PMID:
24246254
12.

Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.

Dawson TM, Starkebaum G, Wood BL, Willkens RF, Gown AM.

J Rheumatol. 2001 Jan;28(1):47-53.

PMID:
11196542
13.

Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?

Georgescu L, Paget SA.

Drug Saf. 1999 Jun;20(6):475-87. Review.

PMID:
10392665
14.

Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.

Maruani A, Wierzbicka E, Machet MC, Abdallah-Lotf M, de Muret A, Machet L.

J Am Acad Dermatol. 2007 Nov;57(5 Suppl):S69-71.

PMID:
17938029
15.

Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.

Tajima S, Takanashi Y, Koda K, Fukayama M.

Pathol Int. 2015 Dec;65(12):661-5. doi: 10.1111/pin.12346. Epub 2015 Oct 13.

PMID:
26459854
16.

Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.

Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, Kimura Y, Takeuchi M, Yoshida M, Ishibashi Y, Nakashima S, Sugita Y, Miura O, Ohshima K.

Eur J Haematol. 2013 Jul;91(1):20-8. doi: 10.1111/ejh.12116. Epub 2013 May 13. Erratum in: Eur J Haematol. 2013 Dec;91(6):565.

PMID:
23560463
17.

Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin.

Clarke LE, Junkins-Hopkins J, Seykora JT, Adler DJ, Elenitsas R.

J Am Acad Dermatol. 2007 Apr;56(4):686-90. Epub 2006 Dec 1.

PMID:
17141365
18.

Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate.

Tournadre A, D'Incan M, Dubost JJ, Franck F, Déchelotte P, Souteyrand P, Soubrier M.

Mayo Clin Proc. 2001 Aug;76(8):845-8. Review.

PMID:
11499826
19.

Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection.

Lioté F, Pertuiset E, Cochand-Priollet B, D'Agay MF, Dombret H, Numéric P, D'Anglejan G, Kuntz D.

J Rheumatol. 1995 Jun;22(6):1174-8.

PMID:
7674250
20.

CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.

Hatachi S, Kunitomi A, Aozasa K, Yagita M.

Mod Rheumatol. 2010 Oct;20(5):500-5. doi: 10.1007/s10165-010-0300-z. Epub 2010 May 1.

PMID:
20437072
Items per page

Supplemental Content

Write to the Help Desk